choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Low percentage of women in clinical trials: what implications?

prof. Jana Brguljan Hitij

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

White coat hypertension: is the gemder difference real?

prof. Gianfranco Parati, MD, FESC

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Women perception of the risk of hypertension and CV diseases

dr n. med. Anna Szyndler

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Assisted reproductive therapies and risk of hypertansion

Emrush Rexhaj

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Monitoring women before, during and after pregnancy: the POPPY study

Ian Wilkinson

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Gender ascpects of resistant and malignant hypertension

prof. dr hab. n. med. Andrzej Januszewicz

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

New data on women and hypertansion: what impact on future guidelines?

prof. Reinhold Kreutz

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Assosciation of BP with CV complications according to gender: is the difference real?

prof. Teemu Niiranen

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

RAS blockers in women with childbearing potential: how to handle?

Prof. Massimo Volpe MD, FAHA, FESC

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Sex-differences in hypertension management: does it matter?

prof. Christian Delles

choroby sercowo-naczyniowe

IX European Forum on Hypertension (2025)

Can pharmacist collaboration be helpful to support adherence?

prof. Marie Schneider

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Sex hormones and BP regulation

Renata Cifkova

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Salt and salt sensivity of BP in women

Pr Dr Antoinette Pechère-Bertschi

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Autonomic nerve activity in women

prof. dr hab. n. med. Dagmara Hering

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Endothelin and the RAAS in pre-eclampsia: what role?

prof. A.H. Jan Danser

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Sex diffrences in gut microbiota composiotion

Barbara Verhaar

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Polygenic risk scores for BP and hypertensive disorders of pregnancy

Jouko Marko Nurkkala

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Endometriosis and risk of hypertension

Gabriella Masszi

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Polycystic ovary syndrome: an unrecognized CV risk factor?

prof. Stamatina Iliodromiti

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Left ventricular hypertrophy and atrial fibrillation

Eva Gerdts

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Arterial structure and function

dr Rosa Maria Bruno

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

BP variability

prof. Grzegorz Bilo

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Validating BP-measuring devices: what about pregnancy (on-line)

Tomas Lucca Bothe

choroby sercowo-naczyniowe

VIII European Forum on Hypertension (2024)

Heart failure with preserved ejection fraction and AF

prof. Sverre Erik Kjeldsen